Bingyue Pan

Bingyue Pan

Auto-generated profile, based on publicly available information

Bingyue Pan

College of Bioinformatics Science and Technology Harbin Medical University Harbin 150081 P. R. China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2025 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
YSYinchun Su
Yinchun Su
JWJiashuo Wu
Jiashuo Wu
XZXilong Zhao
Xilong Zhao
YHYue Hao
Yue Hao
ZWZiyi Wang
Ziyi Wang
JHJunwei Han
Junwei Han

2 January 2024 in GigaScience
Verified
Journal Article
Open access
YHYalan He
Yalan He
JLJiyin Lai
Jiyin Lai
QWQian Wang
Qian Wang
BPBingyue Pan
Bingyue Pan
SLSiyuan Li
Siyuan Li
JHJunwei Han
Junwei Han
Background: Single-sample pathway enrichment analysis is an effective approach for identifying cancer subtypes and pathway biomarkers, facilitating the development of precision medicine. However, the existing approaches focused on investigating the changes in gene expression levels but neglected somatic mutations, which play a crucial role in cancer development. Findings: In this study, we proposed a novel single-sample mutation-based pathway analysis approach (ssMutPA) to infer individualized pathway activities by integrating somatic mutation data and the protein–protein interaction network. For each sample, ssMutPA first uses local and global weighted strategies to evaluate the effects of genes from mutations according to the network topology and then calculates a single-sample mutation-based pathway enrichment score (ssMutPES) to reflect the accumulated effect of mutations of each pathway. To illustrate the performance of ssMutPA, we applied it to 33 cancer cohorts from The Cancer Genome Atlas database and revealed patient stratification with significantly different prognosis in each cancer type based on the ssMutPES profiles. We also found that the identified characteristic pathways with high overlap across different cancers could be used as potential prognosis biomarkers. Moreover, we applied ssMutPA to 2 melanoma cohorts with immunotherapy and identified a subgroup of patients who may benefit from therapy. Conclusions: We provided evidence that ssMutPA could infer mutation-based individualized pathway activity profiles and complement the current individualized pathway analysis approaches focused on gene expression data, which may offer the potential for the development of precision medicine. ssMutPA is available at https://CRAN.R-project.org/package=ssMutPA.

14 January 2025 in Advanced Intelligent Systems
Verified
Journal Article
Open access
YSYinchun Su
Yinchun Su
SLSiyuan Li
Siyuan Li
QWQian Wang
Qian Wang
BPBingyue Pan
Bingyue Pan
JLJiyin Lai
Jiyin Lai
QKQingfei Kong
Qingfei Kong
Immunotherapy has revolutionized cancer treatment, but predicting patient response remains challenging. Herein, we present iPRISM (Intelligent Predicting Response to cancer Immunotherapy through Systematic Modeling), which is a novel network‐based model that integrates multiomics data to predict immunotherapy outcomes. In this approach, iPRISM incorporates gene expression, biological functional network, tumor microenvironment characteristics, immune‐related pathways, and clinical data to provide a comprehensive view of factors influencing immunotherapy efficacy. Using stepwise logistic regression, we identified key predictive features and validated iPRISM across multiple cohorts including melanoma, bladder cancer, non‐small cell lung cancer, and stomach adenocarcinoma. We also find that iPRISM outperforms the existing methods, achieving high predictive accuracy and demonstrating significant prognostic value for overall and progression‐free survival. By identifying key genetic and immunological factors, this model provides a new insight for more personalized treatment strategies and combination therapies to overcome resistance mechanisms. iPRISM can be accessed at CRAN: https://CRAN.R‐project.org/package=iPRISM.